Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma

Stopped Study enrollment was terminated due to a corporate strategic decision unrelated to patient safety.

Conditions

• Soft Tissue Sarcoma

Interventions

• DRUG: Pomalidomide

Sponsor

Celgene